CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock, a biotechnology company focused on discovering and developing drugs that selectively target supracellular activation of growth factors in the disease microenvironment, today announced that Elan Ezickson, Chief Operating Officer and Head of Corporate Development, will present a company overview at the Jefferies 2016 Healthcare Conference on Tuesday, June 7, 2016, at 2:00 p.m. EST in New York, NY.
